ADGRL3 and cancer: The KEGG enrichment in CL3 reflected a heterogeneous landscape, encompassing PI3K–Akt signaling, transcriptional misregulation in cancer, cell lineage differentiation, and inflammatory pathways such as AGE–RAGE and the intestinal immune network (Figure 5h).